Literature DB >> 23619956

Superselective intraophthalmic artery chemotherapy in a nonhuman primate model: histopathologic findings.

Brian C Tse1, Jena J Steinle, Dianna Johnson, Barrett G Haik, Matthew W Wilson.   

Abstract

IMPORTANCE: We describe the histopathologic findings in a nonhuman primate (NHP) model of superselective intraophthalmic artery chemotherapy (SSIOAC), detailing ocular and orbital vascular adverse effects.
OBJECTIVE: To further document, using comprehensive ocular and orbital histopathology, previously reported toxic effects observed with real-time ophthalmoscopy during SSIOAC in a NHP model.
DESIGN: Comparative interventional case series.
SETTING: Preclinical trial approved under the guidelines of the Institutional Animal Care and Utilization committee. PARTICIPANTS: Six adult male rhesus macaques (Macacca mulatta).
INTERVENTIONS: The right eye of each NHP was treated with 3 cycles of SSIOAC using either melphalan (5 mg/30 mL) or carboplatin (30 mg/30 mL). Both eyes in each animal were enucleated 6 hours after the final procedure, before euthanasia and formalin perfusion of the NHP; we then performed orbital dissection of the arterial vasculature and optic nerves. MAIN OUTCOME MEASURES: Histopathologic examination of the eyes, optic nerves, and orbital vessels of the 6 treated NHPs.
RESULTS: We found leukostasis with retinal arteriole occlusion in all treated eyes. Retinal endothelial cells stained positive for 2 inflammatory markers, intercellular adhesion molecule 1 and interleukin 8. Transmission electron microscopy revealed occlusion of the retinal vessels with ultrastructural changes in the endothelial cells and surrounding pericytes. Additional findings included nerve fiber layer infarcts, central retinal artery thrombosis, hypertrophy and occlusion of choroidal arteries with disruption of the internal elastic lamina, patchy choroidal inflammation, and birefringent intravascular foreign bodies. Orbital findings included ophthalmic artery and central retinal artery wall dissection, fracturing of the internal elastic lamina, intimal hyperplasia, and eyelid vessel damage. Optic nerves displayed hemorrhage, leukostasis, and foreign body crystallization. Control eyes, optic nerves, and orbital vessels were normal. CONCLUSIONS AND RELEVANCE: Histopathologic examination of our nonhuman primate model for SSIOAC revealed significant toxic effects in the ocular and orbital vasculature. These findings substantiate previous observations with real-time retinal imaging and parallel reported vascular toxic effects in children with retinoblastoma treated with SSIOAC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23619956      PMCID: PMC4251809          DOI: 10.1001/jamaophthalmol.2013.2065

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  22 in total

1.  Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.

Authors:  Francis L Munier; Maja Beck-Popovic; Aubin Balmer; Marie-Claire Gaillard; Etienne Bovey; Stefano Binaghi
Journal:  Retina       Date:  2011-03       Impact factor: 4.256

2.  Validating a nonhuman primate model of super-selective intraophthalmic artery chemotherapy: comparing ophthalmic artery diameters.

Authors:  Lauren C Ditta; Asim F Choudhri; Brian C Tse; Mark M Landers; Barrett G Haik; Jena J Steinle; J Scott Williams; Matthew W Wilson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-27       Impact factor: 4.799

3.  Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.

Authors:  Carol L Shields; Carlos G Bianciotto; Pascal Jabbour; Gregory C Griffin; Aparna Ramasubramanian; Robert Rosenwasser; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2011-06-13

4.  Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.

Authors:  Carlo Venturi; Sandra Bracco; Alfonso Cerase; Samuele Cioni; Paolo Galluzzi; Paola Gennari; Ignazio M Vallone; Rebecca Tinturini; Cesare Vittori; Sonia De Francesco; Mauro Caini; Alfonso D'Ambrosio; Paolo Toti; Alessandra Renieri; Theodora Hadjistilianou
Journal:  Acta Ophthalmol       Date:  2012-01-23       Impact factor: 3.761

5.  Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.

Authors:  Ralph C Eagle; Carol L Shields; Carlos Bianciotto; Pascal Jabbour; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2011-07-11

6.  Real-time ophthalmoscopic findings of superselective intraophthalmic artery chemotherapy in a nonhuman primate model.

Authors:  Matthew W Wilson; John S Jackson; Blanca X Phillips; Jacquelyn Buchanan; Sharon Frase; Fan Wang; Jena J Steinle; Clinton F Stewart; Timothy D Mandrell; Barrett G Haik; J Scott Williams
Journal:  Arch Ophthalmol       Date:  2011-11

7.  A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Authors:  David H Abramson; Ira J Dunkel; Scott E Brodie; Jonathan W Kim; Y Pierre Gobin
Journal:  Ophthalmology       Date:  2008-03-14       Impact factor: 12.079

Review 8.  Isolated limb perfusion with melphalan in the treatment of malignant melanoma of the extremities: a systematic review of randomised controlled trials.

Authors:  Marko B Lens; Martin Dawes
Journal:  Lancet Oncol       Date:  2003-06       Impact factor: 41.316

Review 9.  High-dose intravenous melphalan: a review.

Authors:  B L Samuels; J D Bitran
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544

10.  Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding.

Authors:  Jonathan Kim; Huy Do; Peter Egbert
Journal:  Clin Ophthalmol       Date:  2011-11-24
View more
  12 in total

Review 1.  Management of retinoblastoma in children: current status.

Authors:  Guillermo Chantada; Paula Schaiquevich
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

2.  Fluorescein angiography findings in both eyes of a unilateral retinoblastoma case during intra-arterial chemotherapy with melphalan.

Authors:  Cem Ozgonul; Neeraj Chaudhary; Raymond Hutchinson; Steven M Archer; Hakan Demirci
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

3.  Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.

Authors:  Anthony B Daniels; Michael T Froehler; Janene M Pierce; Amy H Nunnally; M Wade Calcutt; Thomas M Bridges; David C LaNeve; Phillip E Williams; Kelli L Boyd; Michelle L Reyzer; Craig W Lindsley; Debra L Friedman; Ann Richmond
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

Review 4.  Intra-arterial chemotherapy in retinoblastoma - A paradigm change.

Authors:  Fairooz P Manjandavida; Christina Stathopoulos; Jing Zhang; Santhosh G Honavar; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

5.  Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach.

Authors:  Anthony B Daniels; Michael T Froehler; Amy H Nunnally; Janene M Pierce; Ivan Bozic; Cameron A Stone; Pranav R Santapuram; Yuankai K Tao; Kelli L Boyd; Lauren E Himmel; Sheau-Chiann Chen; Liping Du; Debra L Friedman; Ann Richmond
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-03-01       Impact factor: 4.799

6.  Histopathologic Observations of Eyes in Exenterated Orbits After Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Adenoid Cystic Carcinoma of the Lacrimal Gland.

Authors:  Sophie D Liao; Benjamin P Erickson; Neha Kapila; Sander R Dubovy; David T Tse
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 May-Jun 01       Impact factor: 2.011

7.  Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review.

Authors:  Jasmine H Francis; David H Abramson; Y Pierre Gobin; Brian P Marr; Ira J Dunkel; Elyn R Riedel; Scott E Brodie
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

8.  Topotecan Delivery to the Optic Nerve after Ophthalmic Artery Chemosurgery.

Authors:  Paula Taich; Flavio Requejo; Marcelo Asprea; Mariana Sgroi; Pierre Gobin; David H Abramson; Guillermo Chantada; Paula Schaiquevich
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

9.  Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.

Authors:  Carley M Bogan; Jessica V Kaczmarek; Janene M Pierce; Sheau-Chiann Chen; Kelli L Boyd; Marion W Calcutt; Thomas M Bridges; Craig W Lindsley; Jennifer B Nadelmann; Albert Liao; Terry Hsieh; David H Abramson; Jasmine H Francis; Debra L Friedman; Ann Richmond; Anthony B Daniels
Journal:  Br J Ophthalmol       Date:  2021-05-10       Impact factor: 4.638

Review 10.  Lessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine.

Authors:  Michael A Dyer
Journal:  Trends Mol Med       Date:  2016-08-23       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.